Triggering of inflammatory response by myeloperoxidase-oxidized LDLAn oral presentation of the data was given before the Congress of the Beligian Society of Internal Medicine
| Autor: | Michel Vanhaeverbeek, Dany Brohée, Ilham Legssyer, Sajida Babar, Jean Ducobu, Claude Remacle, Paul Delrée, Roger Lema KisokaR.L. Kisoka, Pierre Van Antwerpen, N. Moguilevsky, Karim Zouaoui Boudjeltia |
|---|---|
| Rok vydání: | 2006 |
| Předmět: | |
| Zdroj: | Biochemistry and Cell Biology. 84:805-812 |
| ISSN: | 1208-6002 0829-8211 |
| DOI: | 10.1139/o06-061 |
| Popis: | The oxidation theory proposes that LDL oxidation is an early event in atherosclerosis and that oxidized LDL contributes to atherogenesis in triggering inflammation. In contrast to the copper-modified LDL, there are few studies using myeloperoxidase-modified LDL (Mox-LDL) as an inflammation inducer. Our aim is to test whether Mox-LDL could constitute a specific inducer of the inflammatory response. Albumin, which is the most abundant protein in plasma and which is present to an identical concentration of LDL in the intima, was used for comparison. The secretion of IL-8 by endothelial cells (Ea.hy926) and TNF-α by monocytes (THP-1) was measured in the cell medium after exposure of these cells to native LDL, native albumin, Mox-LDL, or Mox-albumin. We observed that Mox-LDL induced a 1.5- and 2-fold increase (ANOVA; P < 0.001) in IL-8 production at 100 µg/mL and 200 µg/mL, respectively. The incubation of THP-1 cells with Mox-LDL (100 µg/mL) increased the production of TNF-α 2-fold over the control. Native LDL, albumin, and Mox-albumin showed no effect in either cellular types. The myeloperoxidase-modified LDL increase in cytokine release by endothelial and monocyte cells and by firing both local and systemic inflammation could induce atherogenesis and its development. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|